Internal Medicine · Brooklyn, NY
NPI
1790779403
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
322 Linden Blvd
Brooklyn, NY, 11226
Phone (718) 282-1570
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
518 services
Medicare patients, 2024
150
Average age 75
Drug cost, 2024
$1.3M
12,100 prescriptions
Company payments, 2025
$1,122
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven Liverpool was code 99214 (office e&m - established), 318 times for 137 patients. In total Steven Liverpool billed 518 services in 13 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 318 | 137 | $71.44 | $23K |
| 99213 Office E&M - Established | Office | 55 | 46 | $57.84 | $3,181 |
| 99215 Office E&M - Established | Office | 53 | 41 | $107.70 | $5,708 |
By year: 2022 $38K for 514 services; 2023 $53K for 563 services; 2024 $39K for 518 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven Liverpool prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,009 prescriptions and refills. In total Steven Liverpool wrote 12,100 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,009 | 2,826 | 305 | $11K |
| Amlodipine Besylate Generic | 657 | 1,818 | 208 | $3,903 |
| Meloxicam Generic | 510 | 695 | 153 | $2,154 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 460 | 1,302 | 137 | $12K |
| Losartan Potassium Generic | 364 | 1,028 | 122 | $3,842 |
| Metformin Hcl Generic | 338 | 1,001 | 114 | $2,673 |
| Glipizide-Metformin Glipizide/Metformin Hcl | 323 | 887 | 99 | $11K |
| Atenolol-Chlorthalidone Atenolol/Chlorthalidone | 295 | 801 | 84 | $6,587 |
| Rosuvastatin Calcium Generic | 272 | 710 | 89 | $3,518 |
| Metoprolol Succinate Generic | 232 | 651 | 74 | $4,472 |
| Hydrochlorothiazide Generic | 210 | 628 | 73 | $581 |
| Nifedipine Er Nifedipine | 207 | 544 | 60 | $7,095 |
| Amlodipine Besylate-Benazepril Amlodipine Besylate/Benazepril | 205 | 518 | 50 | $3,528 |
| Furosemide Generic | 192 | 452 | 61 | $626 |
| Famotidine Generic | 190 | 386 | 65 | $2,441 |
Brand drugs: 1,525 claims; generic drugs: 10,394 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven Liverpool $1,122 ($1,122 in general payments such as food, travel and fees) from 13 companies. The largest payer was Novo Nordisk Inc with $271.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 11 | $271 |
| Exact Sciences Corporation EXAS | 5 | $148 |
| Lilly USA, LLC LLY | 5 | $128 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $125 |
| ViiV Healthcare Company GSK | 4 | $103 |
| Amgen Inc. AMGN | 4 | $86.13 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $70.95 |
| Medtronic, Inc. MDT | 2 | $44.79 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $42.52 |
| Astellas Pharma US Inc 4503.T | 1 | $30.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.